Co-Director of Robotic Surgery Mario Leitao, Jr., describes the emerging role and clear benefits of the robotic platform for operating on gynecologic cancers.
Gynecologic oncologist Nadeem Abu-Rustum discusses the prognostic and therapeutic power of sentinel lymph node mapping in gynecologic cancers.
Gynecologic oncologist Elizabeth Jewell discusses the fluorescent dye surgical platform in sentinel lymph node mapping for cervical and endometrial cancer detection.
Memorial Sloan Kettering has a multidisciplinary team approach to screening, counseling, and treating women with endometrial cancer. Recent progress in laproscopic and robotic techniques has transformed the treatment of this malignancy, resulting in greater surgical precision, fewer complications, and shorter hospital stays when compared with open abdominal surgery. Our outcomes after surgery for both advanced and recurrent disease are among the best in the world.
We employ the latest da Vinci® Surgical System platforms and routinely perform laproscopic and robotic-assisted hysterectomies and lymph node dissections that require an average length of stay of only one day and such benefits as decreased postoperative pain, improved cosmetic results, and faster recovery. In addition, the sensitivity and specificity of our innovative sentinel lymph node mapping approach spare many young women from complete lymph node dissection and possible attendant complications.